4//SEC Filing
HOWSON TAMAR D 4
Accession 0000899243-22-025710
CIK 0001262104other
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 4:26 PM ET
Size
9.1 KB
Accession
0000899243-22-025710
Insider Transaction Report
Form 4
MEI Pharma, Inc.MEIP
HOWSON TAMAR D
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-07-05+87,500→ 87,500 totalExercise: $0.54Exp: 2032-07-05→ Common Stock (87,500 underlying)
Holdings
- 50,000
Stock Option (Right to Buy)
Exercise: $3.49Exp: 2030-07-02→ Common Stock (50,000 underlying) - 50,000
Stock Option (Right to Buy)
Exercise: $2.95Exp: 2031-07-01→ Common Stock (50,000 underlying) - 60,000
Stock Option (Right to Buy)
Exercise: $2.52Exp: 2029-07-01→ Common Stock (60,000 underlying)
Footnotes (3)
- [F1]The options will vest in equal monthly installments over twelve months.
- [F2]40,000 of the options vested on July 1, 2020, and are currently exercisable and 20,000 options will vest in equal monthly installments over thirty-six months beginning July 1, 2019.
- [F3]All of such options are presently exercisable.
Documents
Issuer
MEI Pharma, Inc.
CIK 0001262104
Entity typeother
Related Parties
1- filerCIK 0001202286
Filing Metadata
- Form type
- 4
- Filed
- Jul 6, 8:00 PM ET
- Accepted
- Jul 7, 4:26 PM ET
- Size
- 9.1 KB